Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments

[twinklestars]

Also KarXT, BIIB-104, BI-425809, PF-03463275, and ASP-4345

Update to Medications Currently in Trials for Schizophrenia (Spring 2021)

Medications in development, phase 2/3 Spring 2021 This list does not include medications that do not have current trials underway, even though they may be in development. It does not include phase 1 trials or drugs in preclinical testing (not enough info to be worthwhile). It does not include supplements, or already approved medications being repurposed (like levetiracetam, telmisartan) or reformulations of existing medication as an injectable or sublingual. It does not include other therapies like rTMS. Maybe I will try to do a list of those later. These studies are currently listed on clinicaltrials.gov as: 1. Active, not recruiting, 2. Enrolling by invitation, 3. Recruiting, or 4. Not …